NVE Corporation 10-Q Summary: Quarter Ended June 30, 2009
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for NVE Corporation, a developer and seller of spintronic devices (nanotechnology relying on electron spin). The report covers the quarterly period ended June 30, 2009 (the first quarter of fiscal year 2010). The company is an accelerated filer incorporated in Minnesota.
Key Financial Metrics
| Metric | Q1 2010 (Ended June 30, 2009) | Q1 2009 (Ended June 30, 2008) |
|---|---|---|
| Total Revenue | $6,834,532 | $4,863,786 |
| Gross Profit | $4,943,109 | $3,456,354 |
| Gross Margin | 72.3% | 71.1% |
| Net Income | $2,938,932 | $1,902,616 |
| Diluted EPS | $0.61 | $0.40 |
| Operating Cash Flow | $4,792,111 | $3,519,925 |
| Cash & Cash Equivalents | $1,251,561 | $1,838,391 |
| Total Marketable Securities | $39,367,094 | $32,446,748 |
| Total Assets | $47,912,084 | $42,566,440 |
| Total Liabilities | $2,318,293 | $998,869 |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 40.5% year-over-year. This was driven by a 21.7% increase in product sales (due to new customers and higher volume) and a 310.9% surge in contract research and development (R&D) revenue.
- Profitability: Net income rose 54.5% to $2.94 million. Gross margin improved slightly to 72.3%.
- Expense Management: R&D expenses decreased 30.8% as resources were reallocated to billable contract R&D projects. Selling, general, and administrative (SG&A) expenses increased 20.1% due to higher salaries and commissions.
- Liquidity: While cash and cash equivalents decreased by $623,502 due to net investing activities (purchases of marketable securities), total liquid assets (cash plus marketable securities) increased to approximately $40.6 million.
- Investment Portfolio: The company holds significant marketable securities ($39.4 million), representing 82% of total assets. Gross unrealized losses on these securities decreased significantly from $969,011 in March 2009 to $61,574 in June 2009.
Outlook, Risks, and Management Commentary
- Outlook: Management believes working capital is adequate for the next 12 months. They noted that the increase in contract R&D revenue may not be representative of future trends and there is no assurance of follow-on contracts.
- Investment Strategy: The primary objective of the investment portfolio is to preserve principal while maximizing after-tax yields. The portfolio consists of government agency obligations, municipal obligations, and corporate bonds. No derivatives are used.
- Risks: Risks include an uncertain economic environment, competition, reliance on key customers, and market risks associated with the large portfolio of marketable securities. There have been no material changes to risk factors from the previous 10-K.
- Stock Repurchase: The Board authorized a $2.5 million stock repurchase plan in January 2009, but no shares were repurchased during this quarter.
Key Facts for Investor Verification
- Sustainability of R&D Revenue: Verify the nature and duration of the new contract R&D agreements that drove a 311% revenue increase, as management explicitly stated this may not be a recurring trend.
- Investment Portfolio Quality: Confirm the credit ratings of the corporate and municipal bonds held, as the company holds a large concentration of assets ($39.4M) in these securities, which recently experienced unrealized losses.
- Cash Flow vs. Cash Balance: Note the divergence between strong operating cash flow ($4.8M) and the decline in cash on hand, driven by the reinvestment of cash into marketable securities.
- Customer Concentration: Review the 10-K for details on customer concentration, as the revenue increase was attributed to "new customers" and "existing customers," implying potential reliance on a limited base.